Y
Yasuhiko Tabata
Researcher at Kyoto University
Publications - 601
Citations - 21043
Yasuhiko Tabata is an academic researcher from Kyoto University. The author has contributed to research in topics: Gelatin & Basic fibroblast growth factor. The author has an hindex of 70, co-authored 601 publications receiving 18737 citations. Previous affiliations of Yasuhiko Tabata include Hokkaido College of Pharmacy & The Nippon Dental University.
Papers
More filters
Journal ArticleDOI
Dual release of growth factor from nanocomposite fibrous scaffold promotes vascularisation and bone regeneration in rat critical sized calvarial defect.
Shruthy Kuttappan,Dennis Mathew,Jun-ichiro Jo,Ryusuke Tanaka,Deepthy Menon,Takuya Ishimoto,Takayoshi Nakano,Shantikumar V. Nair,Manitha B. Nair,Yasuhiko Tabata +9 more
TL;DR: It is suggested that biomimetic nanocomposite scaffold is a promising growth factor delivery vehicle to improve bone regeneration in critical sized bone defects.
Journal ArticleDOI
Mn-doping-induced itinerant-electron ferromagnetism in Cr 2 GeC
TL;DR: In this paper, the magnetism of the Mn-doped phase of a spin-unpolarized GeC was investigated and it was shown that the ferromagnetic band polarization is induced immediately by the Mn doping.
Journal ArticleDOI
Comparison of bone regeneration in a rabbit skull defect by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution
Liu Hong,Yasuhiko Tabata,Masaya Yamamoto,Susumu Miyamoto,Keisuke Yamada,Nobuo Hashimoto,Yoshito Ikada +6 more
TL;DR: Bone regeneration induced by recombinant human bone morphogenetic protein-2 incorporated into a biodegradable gelatin hydrogel with that by rhBMP-2 in aqueous solution increased the bone mineral density (BMD) at the skull defects with implantation time to a significantly higher extent and the integrity of newly generated bone increased with the rhB MP-2 dose.
Journal ArticleDOI
Mesenchymal Stem Cells as a Novel Carrier for Targeted Delivery of Gene in Cancer Therapy Based on Nonviral Transfection
TL;DR: Results supported both the effectiveness of nonviral vectors in transferring the therapeutic gene to MSCs and the feasibility of using MSC’s as a targeted gene delivery carrier, indicating that M SCs could be a promising tumor target delivery vehicle in cancer gene therapy based onnonviral gene recombination.
Journal ArticleDOI
In vivo release of plasmid DNA from composites of oligo(poly(ethylene glycol)fumarate) and cationized gelatin microspheres.
TL;DR: Results show that composites of OPF and cationized gelatin microspheres are able to prolong the availability of plasmid DNA in vivo relative to cationization gelatin micro Spheres alone and provide a promising candidate material for the sustained, controlled release of plasid DNA.